A New Paradigm for Illness Monitoring and Relapse Prevention in Schizophrenia

Completed · Not applicable

Conditions studied: Schizophrenia, Schizoaffective Disorder

In brief

This study was a 2-arm randomized control trial (RCT) designed to test a multi-modal smartphone data collection system that provided mobile monitoring of schizophrenia to detect early signs of relapse. The RCT compared an arm with participants who received treatment as usual with an arm that received the smartphone system for a year.

Key facts

Study ID

NCT01952041

Run by

Dartmouth-Hitchcock Medical Center

People needed

149

Starts

2015-03-13

Expected to finish

2017-08-07

Last updated by the study team

2019-06-21

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnostic and Statistical Manual of Mental Disorders IV (DSM-IV) criteria for schizophrenia, schizoaffective disorder, or psychosis not otherwise specified based on a chart diagnosis
• 18 years or older
• An inpatient psychiatric hospitalization, daytime psychiatric hospitalization, outpatient crisis management, or short-term psychiatric hospital emergency room within 12 months before study entry
• Willing and able to provide informed consent

You may not qualify if…

• Hearing, vision, or motor impairment that make it impossible to operate a smartphone (determined using a demonstration smartphone for screening)
• 6th grade reading level (determined by Wide Range Achievement Test- 4th Edition)

Where it is running

• Zucker Hillside Hospital — Glen Oaks, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.